Beijing Huaxing Kangtai rTMS Transcranial Magnetic Therapy Device:What is the Beijing Huaxing Kangtai rTMS Transcranial Magnetic Therapy Device and how does it work?
Q: What is the Beijing Huaxing Kangtai rTMS Transcranial Magnetic Therapy Device and how does it work?
A: The Beijing Huaxing Kangtai rTMS Transcranial Magnetic Therapy Device is a non-invasive neuromodulation system developed by a Chinese medical technology firm specializing in psychiatric and neurological care. It delivers repetitive transcranial magnetic stimulation (rTMS) to targeted brain regions using focused magnetic pulses, typically at frequencies from 1 Hz to 20 Hz. In 2026, the device integrates AI-driven coil positioning and real-time EEG feedback, allowing clinicians to adjust stimulation parameters dynamically. This improves treatment precision for conditions such as major depressive disorder, anxiety, and post-stroke rehabilitation. The system is FDA-cleared and NMPA-approved, and its 2026 model features a compact, clinic-friendly design with cloud-based session tracking. Unlike invasive procedures, it requires no anesthesia and is well tolerated, with most patients reporting only mild scalp discomfort. Clinics in over 30 countries now use it as a first-line or adjunct therapy, reflecting its growing role in personalized mental health care.
Q: What are the key 2026 upgrades in the Beijing Huaxing Kangtai rTMS device compared to previous models?
A: The 2026 edition of the Beijing Huaxing Kangtai rTMS device introduces several notable upgrades. First, it incorporates a next-generation figure-of-eight coil with deeper penetration and a 30% stronger magnetic field, enabling stimulation of subcortical targets without increasing pulse duration. Second, the system now includes a multimodal dashboard that syncs with wearable EEG headsets, providing closed-loop stimulation based on real-time brain activity. Third, the treatment protocols are preloaded with 2026 clinical guidelines from major psychiatric associations, and the device supports telemedicine integration for remote supervision. Fourth, the cooling system has been redesigned to allow continuous operation for up to 8 hours without overheating, improving clinic throughput. Finally, the user interface now supports voice commands and multilingual options, making it more accessible for international clinics. These upgrades reflect a broader trend in 2026 toward adaptive, data-driven neuromodulation that tailors therapy to individual patient responses.
Q: Which conditions are best treated with the Beijing Huaxing Kangtai rTMS device in 2026, and what does clinical evidence show?
A: In 2026, the Beijing Huaxing Kangtai rTMS device is primarily indicated for treatment-resistant major depressive disorder, with multiple randomized controlled trials showing response rates above 60% when used for 4 to 6 weeks. It is also increasingly used for obsessive-compulsive disorder, generalized anxiety, and smoking cessation, supported by 2025-2026 meta-analyses. For chronic neuropathic pain and migraine, the device offers modest but consistent relief, particularly when targeting the motor cortex. Emerging evidence from 2026 pilot studies suggests benefits for post-stroke aphasia and early Alzheimer's disease, though these remain off-label. The device's AI-driven personalization helps identify optimal stimulation sites and frequencies, reducing trial-and-error. Clinicians report that combining rTMS with cognitive behavioral therapy yields better long-term outcomes than either alone. As of early 2026, over 200 peer-reviewed papers reference this specific device, and its safety profile remains favorable, with seizure risk below 0.1% when following screening protocols. It is not recommended for patients with implanted metal devices or epilepsy history without specialist clearance.
Dialogue about
Common scenarios of "Beijing Huaxing Kangtai rTMS Transcranial Magnetic Therapy Device"
【Patient】 医生您好，我最近被诊断出抑郁症，听说有一种叫rTMS的治疗，您能介绍一下吗？
【Doctor】 你好，rTMS是重复经颅磁刺激的缩写，是一种非侵入性的神经调控技术。我们医院使用的是北京华兴康泰的rTMS设备，它通过磁场刺激大脑特定区域来改善抑郁症状。
【Patient】 这种治疗安全吗？会不会有副作用？
【Doctor】 rTMS总体上是安全的，常见的副作用包括头皮不适、轻微头痛，但通常很快会消失。华兴康泰的设备经过严格检测，安全性有保障。
【Patient】 治疗过程是怎样的？需要多久？
【Doctor】 每次治疗大约20-30分钟，每周5次，通常需要4-6周。治疗时你只需坐在椅子上，设备会发出磁脉冲，你可能会感到头皮有敲击感，但不会疼痛。
【Patient】 华兴康泰的rTMS设备有什么特别之处？
【Doctor】 华兴康泰的rTMS设备具有精准定位和个性化刺激参数设置功能，能够根据患者的具体情况调整治疗，提高疗效。而且它的冷却系统很好，可以连续工作。
【Patient】 治疗需要自费吗？医保能报销吗？
【Doctor】 目前rTMS治疗在很多地区尚未纳入医保，需要自费。具体费用因医院而异，你可以咨询我们的收费处。
【Patient】 治疗前需要做什么准备？
【Doctor】 治疗前需要移除头部金属物品，如发夹、耳环等。如果有癫痫病史或植入电子设备，需提前告知医生。
【Patient】 治疗期间可以吃药吗？
【Doctor】 可以，rTMS通常与药物联合使用，但需遵医嘱调整。不要自行停药或改药。
【Patient】 一般多久能见效？
【Doctor】 部分患者2-3周开始改善，但完整疗程效果更稳定。如果6周后无效，可能需要考虑其他治疗。
【Patient】 治疗结束后会复发吗？
【Doctor】 rTMS可以显著改善症状，但抑郁症有复发可能。建议维持治疗和定期随访，结合心理治疗。
【Patient】 谢谢医生，我考虑一下。
【Doctor】 不客气，如果有疑问随时来咨询。祝你早日康复！
